Skip to main content

October 2020

Department

Research in Review
10/21/2020
JCP Editors
Despite Utility, NGS Testing for Cancer Often Denied Insurance Coverage Expanded genomic panel testing was clinically impactful in nearly two-third of patients with high-risk cancer, yet payers reimbursed only...
Despite Utility, NGS Testing for Cancer Often Denied Insurance Coverage Expanded genomic panel testing was clinically impactful in nearly two-third of patients with high-risk cancer, yet payers reimbursed only...
...
10/21/2020
Journal of Clinical Pathways

Column

Clinical Pathways Program Outcomes and User Experience
Editor's Page
10/21/2020
The cancer care landscape continues to evolve. Not only do oncologists need to stay up to date on the latest treatment options for their patients, but also the age span of the general population is getting...
The cancer care landscape continues to evolve. Not only do oncologists need to stay up to date on the latest treatment options for their patients, but also the age span of the general population is getting...
The...
10/21/2020
Journal of Clinical Pathways
Trending From ACCC
10/21/2020
JCP Editors
In a recent “Ask the Board” column on how clinical pathways are growing, Journal of Clinical Pathways editorial advisory board member Ray Page, DO, PhD, FACOI, FASCO, shared his perspective: “As we continue to see...
In a recent “Ask the Board” column on how clinical pathways are growing, Journal of Clinical Pathways editorial advisory board member Ray Page, DO, PhD, FACOI, FASCO, shared his perspective: “As we continue to see...
In a...
10/21/2020
Journal of Clinical Pathways
Clinical Pathways GPS
10/21/2020
Medicare’s coverage for genetic testing is based on each test meeting a “reasonable and necessary” criteria. The decision on whether to order the test depends on real-world patient needs and what existing literature...
Medicare’s coverage for genetic testing is based on each test meeting a “reasonable and necessary” criteria. The decision on whether to order the test depends on real-world patient needs and what existing literature...
...
10/21/2020
Journal of Clinical Pathways

Feature

Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival
Research Reports
10/21/2020
Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...
Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...
...
10/21/2020
Journal of Clinical Pathways
Supporting Optimal, Value-Based, and Sustainable Cancer Care Delivery
Perspectives
10/21/2020
Abstract: As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a...
Abstract: As the cancer care landscape continues to evolve, oncologists must stay up to date on the latest treatment options for their patients while also navigating the administrative complexities of running a...
...
10/21/2020
Journal of Clinical Pathways